G
George Karpouzas
Researcher at UCLA Medical Center
Publications - 74
Citations - 2805
George Karpouzas is an academic researcher from UCLA Medical Center. The author has contributed to research in topics: Medicine & Rheumatoid arthritis. The author has an hindex of 19, co-authored 55 publications receiving 2283 citations. Previous affiliations of George Karpouzas include Los Angeles Biomedical Research Institute & University of Cologne.
Papers
More filters
Journal ArticleDOI
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
Bevra H. Hahn,Maureen McMahon,Alan H. Wilkinson,W. Dean Wallace,David I. Daikh,John FitzGerald,George Karpouzas,Joan T. Merrill,Daniel J. Wallace,Jinoos Yazdany,Rosalind Ramsey-Goldman,Karandeep Singh,Mazdak A. Khalighi,Soo I. Choi,Maneesh Gogia,Suzanne Kafaja,Mohammad Kamgar,Christine Lau,William J. Martin,Sefali Parikh,Justin Peng,Anjay Rastogi,Weiling Chen,Jennifer M. Grossman +23 more
TL;DR: The management strategies discussed here apply to lupus nephritis in adults, particularly to those receiving care in the United States of America, and include interventions that were available in theUnited States as of April 2011.
Journal ArticleDOI
Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.
Maureen McMahon,Jennifer M. Grossman,Brian J. Skaggs,John FitzGerald,Lori Sahakian,Nagesh Ragavendra,Christina Charles-Schoeman,Karol E. Watson,Weng Kee Wong,Elizabeth R. Volkmann,Weiling Chen,Alan Gorn,George Karpouzas,Michael H. Weisman,Daniel J. Wallace,Bevra H. Hahn +15 more
TL;DR: The presence of dysfunctional proinflammatory HDL was associated with an increased prevalence of carotid plaque and with a higher IMT, and determination of piHDL may help identify patients at risk for atherosclerosis.
Journal ArticleDOI
Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis
Cynthia S. Crowson,Silvia Rollefstad,Eirik Ikdahl,George D. Kitas,Piet L. C. M. van Riel,Sherine E. Gabriel,Sherine E. Gabriel,Eric L. Matteson,Tore K Kvien,Karen M. J. Douglas,Aamer Sandoo,Elke Arts,Solveig Wållberg-Jonsson,Lena Innala,George Karpouzas,Patrick H Dessein,Linda Tsang,Hani El-Gabalawy,Carol A. Hitchon,Virginia Pascual Ramos,Irazú Contreras Yáñez,Petros P. Sfikakis,Evangelia Zampeli,Miguel A. González-Gay,Alfonso Corrales,Mart A F J van de Laar,Harald E. Vonkeman,Inger L. Meek,Anne Grete Semb +28 more
TL;DR: In a large, international cohort of patients with RA, 30% of CVD events were attributable to RA characteristics, indicating that RA characteristics play an important role in efforts to reduce CVD risk among patients withRA.
Journal ArticleDOI
Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease
TL;DR: RA patients without CAD have higher prevalence, extent, and severity of all types of coronary plaque, and quantitative measures of stenotic plaque severity and extent were higher in RA, even after adjustments for cardiac risk factors.
Journal ArticleDOI
A Panel of Biomarkers Is Associated With Increased Risk of the Presence and Progression of Atherosclerosis in Women With Systemic Lupus Erythematosus
Maureen McMahon,Brian J. Skaggs,Jennifer M. Grossman,Lori Sahakian,John FitzGerald,Weng Kee Wong,Elaine V. Lourenço,Nagesh Ragavendra,Christina Charles-Schoeman,Alan Gorn,George Karpouzas,Mihaela Taylor,Karol E. Watson,Michael H. Weisman,Daniel J. Wallace,Bevra H. Hahn +15 more
TL;DR: Whether proinflammatory high‐density lipoprotein and leptin and other biomarkers can be combined into a risk profile, the Predictors of Risk for Elevated Flares, Damage Progression, and Increased Cardiovascular Disease in Patients with SLE (PREDICTS), that could be used to better predict future progression of ATH is examined.